FF-10501: Preliminary Phase I/II data

Preliminary data from 17 patients with relapsed or refractory myelodysplastic syndrome (MDS) or acute myelogenous leukemia (AML) in the Phase I portion of an open-label, dose-escalation, U.S. Phase I/...